Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

$0.33

Movement

0.005 (-1.49%)

as at 4 Jul - Closed (20 mins delayed)

52 Week Range

$0.28 - $0.66

 
1 Year Return

-48.03%

Mach7 Technologies Ltd Chart and Price Data

$0.20
$0.40
$0.60
$0.20
$0.40
$0.60
$0.20
$0.40
$0.60
$0.20
$0.40
$0.60

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $77.54 million
P/E Ratio 1,428.57
Dividend Yield 0.00%
Shares Outstanding 234.97 million
Earnings per share -0.022
Dividend per share N/A
Year To Date Return -17.50%
Earnings Yield 0.07%
Franking -
Share Price

$0.33

Day Change

0.005 (-1.49%)

52 Week Range

$0.28 - $0.66

Yesterday's Close

$0.335

Today's Open

$0.335

Days Range

$0.33 - $0.335

Volume

148,963

Avg. Volume (1 month)

324,686

Turnover

$49,902

as at 4 Jul - Closed

  • Mach7 Technologies Ltd (ASX: M7T)
    Latest News

    Man drawing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why Betr, Centuria Capital, GR Engineering, and Mach7 shares are pushing higher

    These shares are having a good finish to the week. But why?

    Read more »

    A young woman holding her phone smiles broadly and looks excited, after receiving good news.
    Share Gainers

    Why DroneShield, Karoon Energy, Mach7, and Treasury Wine shares are charging higher

    These shares are having a better day than most on Thursday. But why?

    Read more »

    Businessman hand with coins and sprout in network connection. Plant growing on pile of coins money. Money growth concept.
    Growth Shares

    2025 could be a breakthrough year for Mach7 shares: Here's why

    At first glance, the numbers may seem unfavourable, but looks can be deceiving.

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Small Cap Shares

    3 small cap ASX shares to buy for massive returns

    Analysts are tipping these buy-rated stocks to deliver the goods for investors over the next 12 months.

    Read more »

    A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
    Small Cap Shares

    3 small cap ASX shares to buy for very big returns

    Analysts are tipping these buy-rated stocks to deliver the goods for investors over the next 12 months.

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    52-Week Lows

    Why I think this ASX penny stock is a bargain at its 52-week low

    This health tech share hasn't been feeling the love from the market lately. But is there an upside on the…

    Read more »

    a concerned medical doctor examines an Xray from an imaging machine in a hospital setting.
    Earnings Results

    Can this ASX healthcare stock, down 22% in a year, turn the tide after FY24 results?

    How did this ASX healthcare company do in FY24?

    Read more »

    Rising share price chart.
    Small Cap Shares

    3 small cap ASX stocks that could rise 40% to 100%+

    Brokers believes these small caps could be worth a closer look.

    Read more »

    A woman wearing glasses and a black top smiles broadly as she stares at a money yarn full of coins representing the rising JB Hi-Fi share price and rising dividends over the past five years
    Small Cap Shares

    Morgans rates these ASX small-cap shares as best buys

    Big returns could be on the cards for buyers of these small caps according to the broker.

    Read more »

    Three young people in business attire sit around a desk and discuss.
    Small Cap Shares

    3 ASX penny stocks I don't think will be below 80 cents much longer

    These sub-dollar shares are all capable of smashing through to another level, say experts.

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Why this little ASX healthtech share is charging 7% to a 52-week high on Friday

    This health technology share is making its shareholders smile on Friday

    Read more »

    Broker looking at the share price on her laptop with green and red points in the background.
    Small Cap Shares

    Broker says these small cap ASX shares offer big returns potential

    These small cap ASX shares could provide big returns for investors over the next 12 months...

    Read more »

    Frequently Asked Questions

    M7T ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    4th Jul 2025 2025-07-04T16:42:25 Change in substantial holdingYesNo4:42pm41.1M
    3rd Jul 2025 2025-07-03T09:05:45 Notification of cessation of securities - M7TYesNo9:05am413k
    1st Jul 2025 2025-07-01T09:39:30 Initial Director's Interest Notice - TTYesNo9:39am2216k
    1st Jul 2025 2025-07-01T09:36:50 Final Director's Interest Notice - MLYesNo9:36am2170k
    1st Jul 2025 2025-07-01T08:36:30 Update - Notification of buy-back - M7TYesNo8:36am616k
    30th Jun 2025 2025-06-30T16:11:14 Notification of cessation of securities - M7TYesNo4:11pm516k
    30th Jun 2025 2025-06-30T08:34:02 Update - Notification of buy-back - M7TYesNo8:34am616k
    27th Jun 2025 2025-06-27T08:36:02 Update - Notification of buy-back - M7TYesNo8:36am616k
    26th Jun 2025 2025-06-26T08:32:49 Update - Notification of buy-back - M7TYesNo8:32am616k
    25th Jun 2025 2025-06-25T08:31:26 Change of Company SecretaryYesNo8:31am1126k

    About Mach7 Technologies Ltd

    Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.

    Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.

    M7T Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    04 Jul 2025 $0.33 $-0.01 -2.99% 148,963 $0.34 $0.34 $0.33
    03 Jul 2025 $0.34 $0.00 0.00% 150,065 $0.34 $0.34 $0.33
    02 Jul 2025 $0.34 $-0.01 -2.94% 95,868 $0.34 $0.35 $0.34
    01 Jul 2025 $0.34 $0.01 3.03% 64,529 $0.33 $0.35 $0.33
    30 Jun 2025 $0.33 $-0.02 -5.80% 594,389 $0.35 $0.35 $0.33
    27 Jun 2025 $0.35 $-0.01 -2.82% 251,300 $0.36 $0.36 $0.34
    26 Jun 2025 $0.36 $0.01 2.90% 630,857 $0.34 $0.36 $0.34
    25 Jun 2025 $0.35 $0.00 0.00% 273,065 $0.34 $0.35 $0.33
    24 Jun 2025 $0.34 $0.00 0.00% 312,853 $0.35 $0.35 $0.34
    23 Jun 2025 $0.35 $0.00 0.00% 384,729 $0.34 $0.35 $0.34
    20 Jun 2025 $0.35 $0.02 6.06% 543,825 $0.34 $0.36 $0.33
    19 Jun 2025 $0.33 $0.01 3.08% 574,263 $0.32 $0.33 $0.31
    18 Jun 2025 $0.33 $0.01 3.17% 251,089 $0.31 $0.34 $0.31
    17 Jun 2025 $0.32 $-0.01 -3.13% 108,289 $0.32 $0.33 $0.32
    16 Jun 2025 $0.32 $-0.02 -5.97% 162,074 $0.32 $0.33 $0.32
    13 Jun 2025 $0.34 $0.00 0.00% 583,178 $0.34 $0.34 $0.32
    12 Jun 2025 $0.34 $0.02 6.25% 462,147 $0.32 $0.34 $0.31
    11 Jun 2025 $0.32 $-0.01 -3.03% 366,131 $0.33 $0.33 $0.32
    10 Jun 2025 $0.33 $-0.02 -5.71% 527,781 $0.35 $0.35 $0.33
    06 Jun 2025 $0.35 $-0.02 -5.41% 164,310 $0.36 $0.36 $0.35
    05 Jun 2025 $0.37 $0.01 2.78% 48,930 $0.36 $0.37 $0.35

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Jun 2025 Mike Lampron Expiry 1,033,333 $340,999
    As advised by the company. forfeited, 1,189,667 Rights
    31 Dec 2024 Eliot Siegel Buy 112,012 $44,143
    On-market trade.
    12 Dec 2024 Mike Lampron Buy 46,000 $16,330
    On-market trade.
    09 Dec 2024 Mike Lampron Issued 800,000 $284,000
    Issue of securities. 2,223,000 Performance Rights
    05 Dec 2024 Robert Bazzani Buy 54,700 $19,998
    On-market trade.
    03 Dec 2024 Robert Bazzani Buy 27,395 $9,999
    On-market trade.
    02 Dec 2024 Robert Bazzani Buy 53,333 $19,962
    On-market trade.
    28 Nov 2024 Rebecca Thompson Buy 400,000 $148,000
    On-market trade.
    19 Nov 2024 Robert Bazzani Expiry 225,000 $81,000
    Options expired.
    19 Nov 2024 Eliot Siegel Expiry 25,000 $9,000
    Options expired.
    19 Nov 2024 Mike Lampron Expiry 750,000 $270,000
    Options expired.
    30 Sep 2024 Mike Lampron Expiry 402,185 $223,212
    As advised by the company. 1,423,000 Performance Rights, lapsed

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Eliot L Siegel Non-Executive Director Aug 2018
    Dr. Siegel is a thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and also works for the Veterans Affairs Maryland Healthcare System, in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. He is a pioneer and co-founder of United Theranostics, a company created to bring state-of-the-art radiopharmaceuticals to patients for cancer therapy. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organisation as well as the American College of Radiology and the Society of Imaging Informatics in Medicine. He is also a Board member of Carestream Health and serves on advisory boards in medical imaging. He us Risk Management Committee member. Former directorships (last 3 years): Carestream Health.
    Mr Robert John Bazzani Non-Executive ChairmanNon-Executive Director Jan 2020
    Mr Bazzani spent 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a track record of leading and growing businesses. He has played a role in advising clients (public, private, and global subsidiaries) on commercial matters, public transitions, corporate governance, investment banking and law, M&A and has engaged with Government and Regulators. With experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, technology, property, insurances and consumer & industrial markets. He is Risk Management Committee member.
    Ms Teri Jo Thomas Chief Executive OfficerManaging Director Jul 2025
    --
    Ms Rebecca Thompson Non-Executive Director Nov 2023
    Ms Thompson has more than 25 years of financial markets experience gained at global investment banks, listed companies and a fintech start-up. Rebecca's executive career included seven years at J.P, Morgan as the Head of Corporate Broking followed by a role at KPMG Australia as the Head of Capital Advisory and most recently Head of Investor Relations for CSR Limited (ASX:CSR). Rebecca has a skillset across equities, property, and foreign exchange with experience in the real estate, building materials, healthcare, resources and software industries. Stakeholder relations, communications, sustainability and financial analysis are core competencies Other current directorships: Independent Community Living Australia (ICLA), Non-Executive Director; MarketMeter, Non-Executive Director. He is risk Management Committee Chair.
    Ms Naomi Lawrie Company Secretary Jun 2025
    -
    Naomi Lawrie Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 32,877,317 13.63%
    Sandhurst Trustees Ltd (Jmfg Consol A/C) 31,114,880 12.90%
    J P Morgan Nominees Australia Pty Limited 27,668,371 11.47%
    HSBC Custody Nominees (Australia) Limited 22,684,257 9.40%
    Citicorp Nominees Pty Limited 9,721,484 4.03%
    Ubs Nominees Pty Ltd 9,233,020 3.83%
    Pt Dwi Satrya Utama 4,392,959 1.82%
    Padmalwar Prakash 3,569,921 1.48%
    Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.20%
    Perco Group Pty Ltd (F S P A/C) 2,840,000 1.18%
    Microequities Asset Management Pty Ltd (Microeqts Nanocap No 11 A/C) 2,823,641 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) 1,718,707 0.71%
    Supernatural Super Pty Ltd (The Supernatural Super A/C) 1,715,500 0.71%
    Albert Liong Pak-Fai 1,544,189 0.64%
    Bpnt Pty Ltd (Heaney Family Super Fund A/C) 1,539,283 0.64%
    Ty Webb Pty Ltd (Ty Webb A/C) 1,339,444 0.56%
    BNP Paribas Noms Pty Ltd 1,303,411 0.54%
    Mrs Jennifer Lee Pilcher 1,294,856 0.54%
    62 Darlinghurst Road Pty Ltd 1,000,000 0.41%
    HSBC Custody Nominees (Australia) Limited (Gsco Customers A/C) 964,287 0.40%

    Profile

    since

    Note